Cyclin D2 is a GATA4 cofactor in cardiogenesis

Proceedings of the National Academy of Sciences of the United States of America

Volumn 111, Issue 4, 2014, Pages 1415-1420

  Yamak, Abir ^a   Latinkic, Branko V ^b   Dali, Rola ^a   Temsah, Rana ^a   Nemer, Mona ^a  

^a UNIVERSITY OF OTTAWA   (Canada)

^b CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN D2; TRANSCRIPTION FACTOR GATA 4;

AMINO TERMINAL SEQUENCE; ANIMAL EXPERIMENT; ARTICLE; CONGENITAL HEART DISEASE; EMBRYO; HEART DEVELOPMENT; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN PROTEIN INTERACTION; XENOPUS;

GATA TRANSCRIPTION FACTORS; HEART DEVELOPMENT; HEART REPAIR;

AMINO ACID SEQUENCE; ANIMALS; CYCLIN D2; GATA4 TRANSCRIPTION FACTOR; HEART; HUMANS; MOLECULAR SEQUENCE DATA; ORGANOGENESIS; SEQUENCE HOMOLOGY, AMINO ACID; TRANS-ACTIVATORS;

EID: 84893422642     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1312993111     Document Type: Article

References (55)

1. Sherr CJ, Roberts JM (2004) Living with or without cyclins and cyclin-dependent kinases. Genes Dev 18(22):2699-2711.
2. Kato J, Matsushime H, Hiebert SW, Ewen ME, Sherr CJ (1993) Direct binding of cyclin D to the retinoblastoma gene product (pRb) and pRb phosphorylation by the cyclin D-dependent kinase CDK4. Genes Dev 7(3):331-342.
3. Hirai H, Sherr CJ (1996) Interaction of D-type cyclins with a novel myb-like transcription factor, DMP1. Mol Cell Biol 16(11):6457-6467.
4. Matsuura I, et al. (2004) Cyclin-dependent kinases regulate the antiproliferative function of Smads. Nature 430(6996):226-231.
5. Bienvenu F, et al. (2010) Transcriptional role of cyclin D1 in development revealed by a genetic-proteomic screen. Nature 463(7279):374-378.
6. Fu M, et al. (2005) Cyclin D1 inhibits peroxisome proliferator-Activated receptor gamma-mediated adipogenesis through histone deacetylase recruitment. J Biol Chem 280(17):16934-16941.
7. Fu M, et al. (2005) Cyclin D1 represses p300 transactivation through a cyclindependent kinase-independent mechanism. J Biol Chem 280(33):29728-29742.
8. McMahon C, Suthiphongchai T, DiRenzo J, Ewen ME (1999) P/CAF associates with cyclin D1 and potentiates its activation of the estrogen receptor. Proc Natl Acad Sci USA 96(10):5382-5387.
9. Schiewer MJ, et al. (2009) Cyclin D1 repressor domain mediates proliferation and survival in prostate cancer. Oncogene 28(7):1016-1027.
10. Liu W, et al. (2004) Cyclin D3 interacts with human activating transcription factor 5 and potentiates its transcription activity. Biochem Biophys Res Commun 321(4): 954-960.
11. Wang C, et al. (2003) Cyclin D1 repression of peroxisome proliferator-Activated receptor gamma expression and transactivation. Mol Cell Biol 23(17):6159-6173.
12. Sarruf DA, et al. (2005) Cyclin D3 promotes adipogenesis through activation of peroxisome proliferator-Activated receptor gamma. Mol Cell Biol 25(22):9985-9995.
13. Comstock CE, et al. (2011) Cyclin D1 is a selective modifier of androgen-dependent signaling and androgen receptor function. J Biol Chem 286(10):8117-8127.
14. Augello MA, et al. (2013) Convergence of oncogenic and hormone receptor pathways promotes metastatic phenotypes. J Clin Invest 123(1):493-508.
15. Lukaszewicz AI, Anderson DJ (2011) Cyclin D1 promotes neurogenesis in the developing spinal cord in a cell cycle-independent manner. Proc Natl Acad Sci USA 108(28):11632-11637.
16. Sawai CM, et al. (2012) Therapeutic targeting of the cyclin D3:CDK4/6 complex in T cell leukemia. Cancer Cell 22(4):452-465.
17. Kozar K, et al. (2004) Mouse development and cell proliferation in the absence of D-cyclins. Cell 118(4):477-491.
18. Yamak A, et al. (2012) Cyclin D2 rescues size and function of GATA4 haplo-insufficient hearts. Am J Physiol Heart Circ Physiol 303(8):H1057-H1066.
19. Rojas A, et al. (2008) GATA4 is a direct transcriptional activator of cyclin D2 and Cdk4 and is required for cardiomyocyte proliferation in anterior heart field-derived myocardium. Mol Cell Biol 28(17):5420-5431.
20. Pasumarthi KB, Nakajima H, Nakajima HO, Soonpaa MH, Field LJ (2005) Targeted expression of cyclin D2 results in cardiomyocyte DNA synthesis and infarct regression in transgenic mice. Circ Res 96(1):110-118.
21. Zhong W, et al. (2006) Hypertrophic growth in cardiac myocytes is mediated by Myc through a Cyclin D2-dependent pathway. EMBO J 25(16):3869-3879.
22. Angelis E, et al. (2008) A cyclin D2-Rb pathway regulates cardiac myocyte size and RNA polymerase III after biomechanical stress in adult myocardium. Circ Res 102(10): 1222-1229.
23. Lyons I, et al. (1995) Myogenic and morphogenetic defects in the heart tubes of murine embryos lacking the homeo box gene Nkx2-5. Genes Dev 9(13):1654-1666.
24. Wianny F, et al. (1998) G1-phase regulators, cyclin D1, cyclin D2, and cyclin D3: Upregulation at gastrulation and dynamic expression during neurulation. Dev Dyn 212(1):49-62.
25. Vernon AE, Philpott A (2003) The developmental expression of cell cycle regulators in Xenopus laevis. Gene Expr Patterns 3(2):179-192.
26. Nakajima K, et al. (2011) Coordinated regulation of differentiation and proliferation of embryonic cardiomyocytes by a jumonji (Jarid2)-cyclin D1 pathway. Development 138(9):1771-1782.
27. Peng T, Wang L, Zhou SF, Li X (2010) Mutations of the GATA4 and NKX2.5 genes in Chinese pediatric patients with non-familial congenital heart disease. Genetica 138(11-12):1231-1240.
28. Zhang W, et al. (2008) GATA4 mutations in 486 Chinese patients with congenital heart disease. Eur J Med Genet 51(6):527-535.
29. Butler TL, et al. (2010) GATA4 mutations in 357 unrelated patients with congenital heart malformation. Genet Test Mol Biomarkers 14(6):797-802.
30. Yang YQ, et al. (2011) GATA4 loss-of-function mutations in familial atrial fibrillation. Clin Chim Acta 412(19-20):1825-1830.
31. Charron F, et al. (2001) Tissue-specific GATA factors are transcriptional effectors of the small GTPase RhoA. Genes Dev 15(20):2702-2719.
32. Coqueret O (2002) Linking cyclins to transcriptional control. Gene 299(1-2):35-55.
33. Gallagher JM, Komati H, Roy E, Nemer M, Latinkic BV (2012) Dissociation of cardiogenic and postnatal myocardial activities of GATA4. Mol Cell Biol 32(12):2214-2223.
34. Latinkic BV, Kotecha S, Mohun TJ (2003) Induction of cardiomyocytes by GATA4 in Xenopus ectodermal explants. Development 130(16):3865-3876.
35. Grépin C, Nemer G, Nemer M (1997) Enhanced cardiogenesis in embryonic stem cells overexpressing the GATA-4 transcription factor. Development 124(12):2387-2395.
36. Koshiba-Takeuchi K, et al. (2009) Reptilian heart development and the molecular basis of cardiac chamber evolution. Nature 461(7260):95-98.
37. Lange C, Huttner WB, Calegari F (2009) Cdk4/cyclinD1 overexpression in neural stem cells shortens G1, delays neurogenesis, and promotes the generation and expansion of basal progenitors. Cell Stem Cell 5(3):320-331.
38. Ratineau C, Petry MW, Mutoh H, Leiter AB (2002) Cyclin D1 represses the basic helixloop- helix transcription factor, BETA2/NeuroD. J Biol Chem 277(11):8847-8853.
39. Mullany LK, et al. (2008) Distinct proliferative and transcriptional effects of the D-type cyclins in vivo. Cell Cycle 7(14):2215-2224.
40. Tamamori-Adachi M, Goto I, Yamada K, Kitajima S (2008) Differential regulation of cyclin D1 and D2 in protecting against cardiomyocyte proliferation. Cell Cycle 7(23): 3768-3774.
41. Kowalczyk A, et al. (2004) The critical role of cyclin D2 in adult neurogenesis. J Cell Biol 167(2):209-213.
42. Chen S, Shimoda M, Chen J, Matsumoto S, Grayburn PA (2012) Transient overexpression of cyclin D2/CDK4/GLP1 genes induces proliferation and differentiation of adult pancreatic progenitors and mediates islet regeneration. Cell Cycle 11(4): 695-705.
43. Pestell RG (2013) New roles of cyclin D1. Am J Pathol 183(1):3-9.
44. Neuman E, et al. (1997) Cyclin D1 stimulation of estrogen receptor transcriptional activity independent of cdk4. Mol Cell Biol 17(9):5338-5347.
45. Zhang T, Liu WD, Saunee NA, Breslin MB, Lan MS (2009) Zinc finger transcription factor INSM1 interrupts cyclin D1 and CDK4 binding and induces cell cycle arrest. J Biol Chem 284(9):5574-5581.
46. Kehn K, et al. (2007) Functional consequences of cyclin D1/BRCA1 interaction in breast cancer cells. Oncogene 26(35):5060-5069.
47. Aries A, Paradis P, Lefebvre C, Schwartz RJ, Nemer M (2004) Essential role of GATA-4 in cell survival and drug-induced cardiotoxicity. Proc Natl Acad Sci USA 101(18): 6975-6980.
48. Durocher D, Charron F, Warren R, Schwartz RJ, Nemer M (1997) The cardiac transcription factors Nkx2-5 and GATA-4 are mutual cofactors. EMBO J 16(18):5687-5696.
49. Burgess A, et al. (2006) Inhibition of S/G2 phase CDK4 reduces mitotic fidelity. J Biol Chem 281(15):9987-9995.
50. Paradis P, Dali-Youcef N, Paradis FW, Thibault G, Nemer M (2000) Overexpression of angiotensin II type I receptor in cardiomyocytes induces cardiac hypertrophy and remodeling. Proc Natl Acad Sci USA 97(2):931-936.
51. Wang J, et al. (2005) Convergence of protein kinase C and JAK-STAT signaling on transcription factor GATA-4. Mol Cell Biol 25(22):9829-9844.
52. Debrus S, et al. (2005) The zinc finger-only protein Zfp260 is a novel cardiac regulator and a nuclear effector of ?1-Adrenergic signaling. Mol Cell Biol 25(19):8669-8682.
53. Georges R, Nemer G, Morin M, Lefebvre C, Nemer M (2008) Distinct expression and function of alternatively spliced Tbx5 isoforms in cell growth and differentiation. Mol Cell Biol 28(12):4052-4067.
54. Komati H, Maharsy W, Beauregard J, Hayek S, NemerM (2011) ZFP260 is an inducer of cardiac hypertrophy and a nuclear mediator of endothelin-1 signaling. J Biol Chem 286(2):1508-1516.
55. Sive HL, Grainger RM, Harland RM, eds (2000) Early Development of Xenopus laevis: A Laboratory Manual (Cold Spring Harbor Laboratory Press, Woodbury, NY).